Location History:
- Basel, CH (2000)
- Reinach, CH (2007)
Company Filing History:
Years Active: 2000-2007
Title: The Innovative Mind of Stephan Doswald
Introduction
Stephan Doswald is a prominent inventor based in Reinach, Switzerland. With a total of two patents to his name, he has made significant contributions in the field of biocatalytic processes and purification methods in biochemistry. His work not only showcases his creativity and technical skill but also his dedication to advancing pharmaceutical innovations.
Latest Patents
Doswald's latest innovations include two notable patents. The first is titled "Asymmetric reduction of 1,1,1-trifluoroacetone," which describes a scalable biocatalytic process for preparing S-1,1,1-trifluoro-2-propanol. This innovative process achieves an impressive enantiomeric excess of over 99% through the asymmetric microbial reduction of 1,1,1-trifluoroacetone utilizing Baker's yeast. His second patent, "Purification of lipstatin," presents a sophisticated method for purifying lipstatin by leveraging a two-phase system. This method efficiently removes impurities and concentrates lipstatin using innovative phase separation techniques.
Career Highlights
Stephan works at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role involves research and development aimed at enhancing drug formulations and production processes. His contributions at Hoffmann-La Roche have played a crucial role in their ongoing commitment to pioneering therapeutic solutions.
Collaborations
Throughout his career, Doswald has had the opportunity to collaborate with talented colleagues such as Ernst Kupfer and Steven Paul Hanlon. Together, they have pooled their expertise to tackle complex challenges in the field of biochemistry and contribute to the advancement of innovative solutions.
Conclusion
Stephan Doswald exemplifies the spirit of innovation and dedication in the realm of scientific research and invention. His patents underscore his ability to blend creativity with technical expertise, making significant strides in the pharmaceutical field. As he continues to work with leading professionals, the future looks promising for potential breakthroughs that could benefit industries and society alike.